Affineon Health vs Epic In Basket Art
For an Epic site this is the whole inbox decision: switch on what is already in the record system, or buy an agent that works a narrower slice of it properly. Art drafts replies to patient medical advice messages at roughly 150 health systems and is the only product in this category with independent peer reviewed evidence behind it, which is a genuine advantage even though that literature is candid about the limits of what drafting achieved. Affineon does not attempt the whole inbox. It concentrates on laboratory result disposition and prescription renewals, publishes a complete price ladder on its own website, and is a real option for a practice that will never negotiate terms with its record system vendor. The uncomfortable common ground is that both draft text a clinician signs, and the accountability for what goes out sits with that signature.
- It is scoped honestly to two workflows, laboratory result disposition and prescription renewals, rather than claiming the whole inbox, and depth in a narrow lane is what makes an inbox agent survive contact with real volume.
- The commercial disclosure is among the clearest in this index, with a complete price ladder published on the vendor's own site, against a product whose price is invisible inside an enterprise agreement.
- It runs inside the record system with no new application for clinicians to open, and it is a real alternative for practices that will never be large enough to negotiate with their record system vendor.
- It is the only product in this category with independent peer reviewed evidence, and that literature is candid about what the drafts did and did not achieve, which is more than any competitor can show.
- The scale is not comparable: roughly 150 health systems and medical groups, which means the failure modes have been encountered somewhere before your organisation encounters them.
- It is part of the record system rather than integrated with it, governed by the existing agreement, with no separate vendor relationship, security review or data processor to add.
Side by Side
| Axis | A Affineon Health |
E Epic In Basket Art |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Inbox & Messaging AI page.
The published evidence on drafted portal replies, including the studies covering Epic's feature, has tended to find the benefit in cognitive burden rather than in minutes saved, so a business case built on time savings alone should be treated cautiously for either product.
Epic publishes no fairness, subgroup, reading level or language performance disclosure, which matters for a feature drafting patient facing text at national scale, since a reply written above a patient's reading level or in the wrong register fails silently. Affineon publishes no business associate agreement terms, its privacy policy is a generic marketing site policy predating the product, and its evidence is entirely vendor generated. Both products draft replies that a clinician signs, so the attribution and licensure exposure belongs to the person who signs, not the vendor.